# FDA recall Z-1075-2025

> **Oxoid Limited** · Class II · device recall initiated 2024-12-23.

## Product

Lev5, REF CT1587B, 50 Susceptibility discs Levofloxacin 5 ug, IVD, CE 2797

## Reason for recall

Mislabeling;  Levofloxacin Antimicrobial susceptibility disc packaging may  contain Norfloxacin Antimicrobial  Susceptibility discs.

## Distribution

US: VA, CA, NE, MA, FL, CA, MA, NH, WA OUS: Austria, Australia, Brazil, Canada, China, Costa Rica, Germany, Spain, France, United Kingdom, Ghana, Hong Kong, South Korea, Netherlands, Peru, Philippines, Poland, Indonesia

## Key facts

- **Recall number:** Z-1075-2025
- **Recalling firm:** Oxoid Limited
- **Classification:** Class II
- **Product type:** device
- **Status:** Ongoing
- **Initiation date:** 2024-12-23
- **Report date:** 2025-02-12

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Basingstoke, United Kingdom

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1075-2025

## Citation

> AI Analytics. FDA recall Z-1075-2025. Retrieved 2026-07-07 from https://api.ai-analytics.org/recall/Z-1075-2025. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*